829 related articles for article (PubMed ID: 19153574)
1. Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety.
Gatt JM; Nemeroff CB; Dobson-Stone C; Paul RH; Bryant RA; Schofield PR; Gordon E; Kemp AH; Williams LM
Mol Psychiatry; 2009 Jul; 14(7):681-95. PubMed ID: 19153574
[TBL] [Abstract][Full Text] [Related]
2. Association between BDNF Val66Met polymorphism and trait depression is mediated via resting EEG alpha band activity.
Gatt JM; Kuan SA; Dobson-Stone C; Paul RH; Joffe RT; Kemp AH; Gordon E; Schofield PR; Williams LM
Biol Psychol; 2008 Oct; 79(2):275-84. PubMed ID: 18721847
[TBL] [Abstract][Full Text] [Related]
3. Disturbances in selective information processing associated with the BDNF Val66Met polymorphism: evidence from cognition, the P300 and fronto-hippocampal systems.
Schofield PR; Williams LM; Paul RH; Gatt JM; Brown K; Luty A; Cooper N; Grieve S; Dobson-Stone C; Morris C; Kuan SA; Gordon E
Biol Psychol; 2009 Feb; 80(2):176-88. PubMed ID: 18838100
[TBL] [Abstract][Full Text] [Related]
4. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
[TBL] [Abstract][Full Text] [Related]
5. The effects of BDNF Val66Met polymorphism on brain function in controls and patients with multiple sclerosis: an imaging genetic study.
Cerasa A; Tongiorgi E; Fera F; Gioia MC; Valentino P; Liguori M; Manna I; Zito G; Passamonti L; Nisticò R; Quattrone A
Behav Brain Res; 2010 Mar; 207(2):377-86. PubMed ID: 19874854
[TBL] [Abstract][Full Text] [Related]
6. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression.
Frodl T; Schüle C; Schmitt G; Born C; Baghai T; Zill P; Bottlender R; Rupprecht R; Bondy B; Reiser M; Möller HJ; Meisenzahl EM
Arch Gen Psychiatry; 2007 Apr; 64(4):410-6. PubMed ID: 17404118
[TBL] [Abstract][Full Text] [Related]
7. Effects of the BDNF Val66Met polymorphism on neural responses to facial emotion.
Mukherjee P; Whalley HC; McKirdy JW; McIntosh AM; Johnstone EC; Lawrie SM; Hall J
Psychiatry Res; 2011 Mar; 191(3):182-8. PubMed ID: 21310593
[TBL] [Abstract][Full Text] [Related]
8. Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly.
Miyajima F; Ollier W; Mayes A; Jackson A; Thacker N; Rabbitt P; Pendleton N; Horan M; Payton A
Genes Brain Behav; 2008 Jun; 7(4):411-7. PubMed ID: 17973920
[TBL] [Abstract][Full Text] [Related]
9. The brain-derived neurotrophic factor Val66Met polymorphism affects memory formation and retrieval of biologically salient stimuli.
van Wingen G; Rijpkema M; Franke B; van Eijndhoven P; Tendolkar I; Verkes RJ; Buitelaar J; Fernández G
Neuroimage; 2010 Apr; 50(3):1212-8. PubMed ID: 20097294
[TBL] [Abstract][Full Text] [Related]
10. 'Negativity bias' in risk for depression and anxiety: brain-body fear circuitry correlates, 5-HTT-LPR and early life stress.
Williams LM; Gatt JM; Schofield PR; Olivieri G; Peduto A; Gordon E
Neuroimage; 2009 Sep; 47(3):804-14. PubMed ID: 19446647
[TBL] [Abstract][Full Text] [Related]
11. The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression.
Montag C; Weber B; Fliessbach K; Elger C; Reuter M
Psychol Med; 2009 Nov; 39(11):1831-9. PubMed ID: 19335934
[TBL] [Abstract][Full Text] [Related]
12. Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia.
Koolschijn PC; van Haren NE; Bakker SC; Hoogendoorn ML; Hulshoff Pol HE; Kahn RS
Hippocampus; 2010 Sep; 20(9):1010-7. PubMed ID: 19714565
[TBL] [Abstract][Full Text] [Related]
13. The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology.
Nemoto K; Ohnishi T; Mori T; Moriguchi Y; Hashimoto R; Asada T; Kunugi H
Neurosci Lett; 2006 Apr 10-17; 397(1-2):25-9. PubMed ID: 16388901
[TBL] [Abstract][Full Text] [Related]
14. The brain-derived neurotrophic factor VAL66MET polymorphism and cerebral white matter hyperintensities in late-life depression.
Taylor WD; Züchner S; McQuoid DR; Payne ME; MacFall JR; Steffens DC; Speer MC; Krishnan KR
Am J Geriatr Psychiatry; 2008 Apr; 16(4):263-71. PubMed ID: 18263664
[TBL] [Abstract][Full Text] [Related]
15. BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects.
Bueller JA; Aftab M; Sen S; Gomez-Hassan D; Burmeister M; Zubieta JK
Biol Psychiatry; 2006 May; 59(9):812-5. PubMed ID: 16442082
[TBL] [Abstract][Full Text] [Related]
16. BDNF Val66Met polymorphism is associated with higher anticipatory cortisol stress response, anxiety, and alcohol consumption in healthy adults.
Colzato LS; Van der Does AJ; Kouwenhoven C; Elzinga BM; Hommel B
Psychoneuroendocrinology; 2011 Nov; 36(10):1562-9. PubMed ID: 21596481
[TBL] [Abstract][Full Text] [Related]
17. Interaction between BDNF Val66Met and childhood stressful life events is associated to affective memory bias in men but not women.
van Oostrom I; Franke B; Rijpkema M; Gerritsen L; Arias-Vásquez A; Fernández G; Tendolkar I
Biol Psychol; 2012 Jan; 89(1):214-9. PubMed ID: 22033217
[TBL] [Abstract][Full Text] [Related]
18. BDNF Val66Met polymorphism and anxiety/depression symptoms in schizophrenia in a Chinese Han population.
Sun MM; Yang LM; Wang Y; Feng X; Cui KY; Liu LF; Chen ZY
Psychiatr Genet; 2013 Jun; 23(3):124-9. PubMed ID: 23532065
[TBL] [Abstract][Full Text] [Related]
19. The BDNF Val66Met polymorphism predicts rumination and depression differently in young adolescent girls and their mothers.
Hilt LM; Sander LC; Nolen-Hoeksema S; Simen AA
Neurosci Lett; 2007 Dec; 429(1):12-6. PubMed ID: 17959306
[TBL] [Abstract][Full Text] [Related]
20. BDNF Val66Met genotype modulates the effect of childhood adversity on subgenual anterior cingulate cortex volume in healthy subjects.
Gerritsen L; Tendolkar I; Franke B; Vasquez AA; Kooijman S; Buitelaar J; Fernández G; Rijpkema M
Mol Psychiatry; 2012 Jun; 17(6):597-603. PubMed ID: 21577214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
